Cullinan Therapeutics (CGEM) Change in Account Payables (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly Change in Account Payables came in at $1.7 million in Q1 2026, down 3.08% year-on-year from $1.7 million in Q1 2025, and up 289.65% quarter-over-quarter from -$879000.0 in Q4 2025.
Cullinan Therapeutics (CGEM) Change in Account Payables (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 3.08% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was -$892000.0, a 191.5% decrease from a year earlier, with the FY2025 full-year figure at -$839000.0, down 3.33% from the prior year.
- Change in Account Payables rose to $1.7 million in Q1 2026 per CGEM's latest filing, from -$879000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.1 million in Q1 2022 and bottomed at -$3.2 million in Q2 2022.
- The 5-year median for Change in Account Payables is -$434000.0 (2024), against an average of -$38823.5.
- Biggest YoY gain for Change in Account Payables was 292.7% in 2024; the steepest drop was 566.81% in 2024.
- Year by year, Change in Account Payables stood at $1.1 million in 2022, then soared by 34.67% to $1.5 million in 2023, then plunged by 128.15% to -$434000.0 in 2024, then sank by 102.53% to -$879000.0 in 2025, then soared by 289.65% to $1.7 million in 2026.
- Per Business Quant, the three latest CGEM Change in Account Payables figures stand at $1.7 million (Q1 2026), -$879000.0 (Q4 2025), and -$739000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | 1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | -879,000.00 |
| Dec 31, 2025 | -879,000.00 |
| Sep 30, 2025 | -739,000.00 |
| Sep 30, 2025 | -739,000.00 |
| Jun 30, 2025 | -941,000.00 |
| Jun 30, 2025 | -941,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | -434,000.00 |
| Dec 31, 2024 | -434,000.00 |
| Sep 30, 2024 | 560,000.00 |
| Sep 30, 2024 | 560,000.00 |
| Jun 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |